Multi-drug resistant organisms are a problem that continue to grow both in the general population and in the solid organ transplant (SOT) population. It is important to think of antimicrobial stewardship considerations when managing SOT recipients to reduce the risk of development of MDR infections. This includes stewardship both pre- and post-transplant. It is important to understand the downstream effects of using broad spectrum antibiotics pre-transplant and how it can translate to MDROs post-transplant. It is also important to be aware of how to respond to a positive donor culture, whether treatment is indicated or not, as well as how long to treat infections in transplant recipients and manage SOT patients with existing infections pre-transplant. Lastly, there has been several new antibiotics that have come to the market and it is important to understand their role in clinical practice.
Activity Fee: Member - Free / Non-Member - Not Available
Registration for this webinar will be approved for ASHP Members Only. ASHP member ID number is required to register. Find your ASHP membership ID here. Not an ASHP member?
- Describe antimicrobial stewardship considerations in transplant recipients frequently encountered in clinical practice.
- Identify various drug-drug interactions between anti-infectives and immunosuppressants.
- Given case scenarios, discuss personalized infection treatment plans including antibiotic selection and duration.
- Erica Maceira Pharm.D., BCPS, Clinical Pharmacy Specialist - Kidney/Pancreas Transplant, Pharmacy Residency Director; Albany Medical Center, Albany, NY
- Greg Malat Pharm.D., FAST, BCPS, Clinical Transplant Pharmacist; Hospital of the University of Pennsylvania, Philadelphia, PA
- Erin McCreary Pharm.D., BCPS, Antimicrobial Stewardship/Infectious Diseases Clinical Pharmacist Specialist; University of Pittsburgh Medical Center, Pittsburgh, PA
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity will provide 1.0 hour (0.1 CEUs) of continuing pharmacy education credits (ACPE#: 0204-0000-20-037-L01-P).
Continuing pharmacy education (CPE) for this activity will be processed on ASHP's eLearning portal and reported directly to CPE Monitor. After completion of the live webinar, you will process and claim CPE credit online at elearning.ashp.org. Pharmacists will need the enrollment code that will be announced at the end of the webinar and your eProfile ID from NABP to earn CPE credits. Follow the prompts to claim credit within 60 days after completing the activity.
CE Activity Announcement
The ASHP Section of Clinical Specialists and Scientists is recognized for the organization of this webinar continuing education activity.
For questions and comments, please email [email protected].